145 related articles for article (PubMed ID: 28005690)
1. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence.
Jiménez B; Sainz T; Díaz L; Mellado MJ; Navarro ML; Rojo P; González-Tomé MI; Prieto L; Martínez J; de José MI; Ramos JT; Muñoz-Fernandez MÁ;
Pediatr Infect Dis J; 2017 Jun; 36(6):578-583. PubMed ID: 28005690
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
Schtscherbyna A; Pinheiro MF; Mendonça LM; Gouveia C; Luiz RR; Machado ES; Farias ML
Int J Infect Dis; 2012 Dec; 16(12):e872-8. PubMed ID: 23031418
[TBL] [Abstract][Full Text] [Related]
3. Predictors of bone mineral density in human immunodeficiency virus-1 infected children.
Jacobson DL; Spiegelman D; Duggan C; Weinberg GA; Bechard L; Furuta L; Nicchitta J; Gorbach SL; Miller TL
J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):339-46. PubMed ID: 16131991
[TBL] [Abstract][Full Text] [Related]
4. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
Kwak MK; Lee EJ; Park JW; Park SY; Kim B-; Kim TH; Suh K; Koh J-; Lee SH; Byun D-
Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
Puthanakit T; Saksawad R; Bunupuradah T; Wittawatmongkol O; Chuanjaroen T; Ubolyam S; Chaiwatanarat T; Nakavachara P; Maleesatharn A; Chokephaibulkit K
J Acquir Immune Defic Syndr; 2012 Dec; 61(4):477-83. PubMed ID: 22918157
[TBL] [Abstract][Full Text] [Related]
6. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
[TBL] [Abstract][Full Text] [Related]
7. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
Pinto Neto LF; Ragi-Eis S; Vieira NF; Soprani M; Neves MB; Ribeiro-Rodrigues R; Miranda AE
J Clin Densitom; 2011; 14(4):434-9. PubMed ID: 22051092
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density in children and adolescents with perinatal HIV infection.
DiMeglio LA; Wang J; Siberry GK; Miller TL; Geffner ME; Hazra R; Borkowsky W; Chen JS; Dooley L; Patel K; van Dyke RB; Fielding RA; Gurmu Y; Jacobson DL;
AIDS; 2013 Jan; 27(2):211-20. PubMed ID: 23032412
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
Natukunda E; Szubert A; Otike C; Namyalo I; Nambi E; Bamford A; Doerholt K; Gibb DM; Musiime V; Musoke P
PLoS One; 2023; 18(7):e0288877. PubMed ID: 37471330
[TBL] [Abstract][Full Text] [Related]
12. Association between bone mineral density and content and physical growth parameters among children and adolescents diagnosed with HIV: a cross-sectional study.
Zanlorenci S; Martins PC; Alves Junior CAS; Castro JAC; Lima LRA; Petroski EL; Silva DAS
Sao Paulo Med J; 2022; 140(5):682-690. PubMed ID: 35920531
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
Paccou J; Viget N; Drumez E; Cortet B; Robineau O
Med Mal Infect; 2018 Oct; 48(7):442-448. PubMed ID: 29699830
[TBL] [Abstract][Full Text] [Related]
14. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Sophonphan J; Ananworanich J; Puthanakit T;
Antivir Ther; 2017; 22(6):471-479. PubMed ID: 27786155
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
Guillemi S; Harris M; Bondy GP; Ng F; Zhang W; Lima VD; Michaels CE; Belzberg A; Montaner JS
J Clin Densitom; 2010; 13(4):456-61. PubMed ID: 20663695
[TBL] [Abstract][Full Text] [Related]
16. Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.
Aldrovandi GM; Lindsey JC; Jacobson DL; Zadzilka A; Sheeran E; Moye J; Borum P; Meyer WA; Hardin DS; Mulligan K;
AIDS; 2009 Mar; 23(6):661-72. PubMed ID: 19279441
[TBL] [Abstract][Full Text] [Related]
17. Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.
Jacobson DL; Lindsey JC; Gordon CM; Moye J; Hardin DS; Mulligan K; Aldrovandi GM;
AIDS; 2010 Mar; 24(5):687-96. PubMed ID: 20168204
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density and vitamin D concentration: the challenges in taking care of children and adolescents infected with HIV.
Carmo FB; Terreri MT; Succi RCM; Beltrão SV; Gouvea AFTB; Paulino ERC; Machado DM
Braz J Infect Dis; 2017; 21(3):270-275. PubMed ID: 28399423
[TBL] [Abstract][Full Text] [Related]
19. Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.
Atencio P; Cabello A; Conesa-Buendía FM; Pérez-Tanoira R; Prieto-Pérez L; Carrillo I; Álvarez B; Arboiro-Pinel R; Díaz-Curiel M; Herrero-Beaumont G; Mediero A; Górgolas M
BMC Infect Dis; 2021 Jun; 21(1):542. PubMed ID: 34107907
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of bone mineral density in children with vertical infection by HIV].
Torrejón C; Galaz MI; Vizueta E; Álvarez AM; Wu E; Chávez A; Villarroel J; Yohannessen K; Hevia M; Vivanco M; Rivero C; Balboa P
Rev Chilena Infectol; 2018; 35(6):634-641. PubMed ID: 31095183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
